![Michael Dugery](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Michael Dugery
Sociétés | Poste | Début | Fin |
---|---|---|---|
SonoMedix, Inc.
![]() SonoMedix, Inc. Medical SpecialtiesHealth Technology SonoMedix, Inc. engages in the development and commercialization of technology designed for monitoring blood coagulation and hemostatic status. It offers Nano-Acoustic Blood Analyzer platform (NABA) technology that helps to interrogate and detect blood properties at the molecular level. The company was founded by Adam D. Dakin and Michael Dugery on June 6, 2005 and is headquartered in Doylestown, PA. | President | 06/06/2005 | - |
Fondateur | 06/06/2005 | - | |
Directeur Général | 06/06/2005 | 19/03/2010 |
Historique de carrière de Michael Dugery
Anciens postes connus de Michael Dugery
Sociétés | Poste | Début | Fin |
---|---|---|---|
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Corporate Officer/Principal | - | - |
Cordis Corp.
![]() Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Corporate Officer/Principal | - | - |
Bioconnect Systems, Inc.
![]() Bioconnect Systems, Inc. Medical SpecialtiesHealth Technology Bioconnect Systems, Inc. provides surgical implants and techniques that form controlled vascular connections. It offers Optiflow, a family of anastomotic connectors that provides repeatable method for connecting vessels. The company was founded by Michael Dugery and Adam D. Dakin on May 8, 2006 and is headquartered in Ambler, PA. | Fondateur | 08/05/2006 | - |
Corporate Officer/Principal | 08/05/2006 | - |
Formation de Michael Dugery
The Pennsylvania State University | Undergraduate Degree |
University of Pennsylvania | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 3 |
Founder | 2 |
Undergraduate Degree | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Bioconnect Systems, Inc.
![]() Bioconnect Systems, Inc. Medical SpecialtiesHealth Technology Bioconnect Systems, Inc. provides surgical implants and techniques that form controlled vascular connections. It offers Optiflow, a family of anastomotic connectors that provides repeatable method for connecting vessels. The company was founded by Michael Dugery and Adam D. Dakin on May 8, 2006 and is headquartered in Ambler, PA. | Health Technology |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
Cordis Corp.
![]() Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
SonoMedix, Inc.
![]() SonoMedix, Inc. Medical SpecialtiesHealth Technology SonoMedix, Inc. engages in the development and commercialization of technology designed for monitoring blood coagulation and hemostatic status. It offers Nano-Acoustic Blood Analyzer platform (NABA) technology that helps to interrogate and detect blood properties at the molecular level. The company was founded by Adam D. Dakin and Michael Dugery on June 6, 2005 and is headquartered in Doylestown, PA. | Health Technology |
- Bourse
- Insiders
- Michael Dugery
- Expérience